ZBH - Zimmer Biomet Holdings - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98956P1021

Hip, Knee, Sports Medicine, Biologics, Trauma, Orthopedic, Surgical

Zimmer Biomet Holdings Inc is a global medical technology company that designs, manufactures, and markets a wide range of orthopedic reconstructive products. These products include knee and hip replacements, sports medicine solutions, biologics, foot and ankle implants, extremities products, and trauma devices.

The company's product portfolio also features craniomaxillofacial and thoracic solutions, which are used to reconstruct the face and skull, as well as stabilize the chest bones after open heart surgery, trauma, or to correct deformities. Additionally, Zimmer Biomet offers robotic, surgical, and bone cement products that are used in various orthopedic procedures.

Zimmer Biomet's products and solutions are designed to treat patients with disorders or injuries affecting bones, joints, or supporting soft tissues. The company's customers include orthopedic surgeons, neurosurgeons, hospitals, distributors, dealers, and other healthcare professionals. Zimmer Biomet also partners with agents, healthcare purchasing organizations, and buying groups to deliver its products and solutions to the market.

With a rich history dating back to 1927, Zimmer Biomet has evolved over the years to become a leading player in the medical technology industry. The company changed its name from Zimmer Holdings Inc to Zimmer Biomet Holdings Inc in June 2015, following its merger with Biomet Inc. Today, Zimmer Biomet is headquartered in Warsaw, Indiana, and operates globally, with a strong commitment to innovation, quality, and customer satisfaction.

For more information about Zimmer Biomet's products, solutions, and services, please visit their website at https://www.zimmerbiomet.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ZBH - Zimmer Biomet Holdings  - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for ZBH - Zimmer Biomet Holdings  - Stock & Dividends

ZBH Stock Overview

Market Cap in USD 22,577m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2001-07-25

ZBH Stock Ratings

Growth 5y -13.5
Fundamental 21.7
Dividend 42.9
Rel. Performance vs Sector -1.79
Analysts 3.41/5
Fair Price Momentum 101.69 USD
Fair Price DCF 120.79 USD

ZBH Dividends

Dividend Yield 12m 0.86%
Yield on Cost 5y 0.76%
Dividends CAGR 5y 0.61%
Payout Consistency 98.4%

ZBH Growth Ratios

Growth 12m -19.47%
Growth Correlation 12m 0%
Growth Correlation 3m -57%
CAGR 5y -2.39%
CAGR/Mean DD 5y -0.11
Sharpe Ratio 12m -1.17
Alpha vs SP500 12m -41.43
Beta vs SP500 5y weekly 1.07
ValueRay RSI 70.36
Volatility GJR Garch 1y 20.83%
Price / SMA 50 0.31%
Price / SMA 200 -4.85%
Current Volume 1399.4k
Average Volume 20d 1518.4k

External Links for ZBH Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of ZBH stocks?
As of July 27, 2024, the stock is trading at USD 111.29 with a total of 1,399,400 shares traded.
Over the past week, the price has changed by +0.71%, over one month by +2.94%, over three months by -6.55% and over the past year by -18.77%.
What are the forecast for ZBH stock price target?
According to ValueRays Forecast Model, ZBH Zimmer Biomet Holdings will be worth about 111.8 in July 2025. The stock is currently trading at 111.29. This means that the stock has a potential upside of +0.44%.
Issuer Forecast Upside
Wallstreet Target Price 132.7 19.3
Analysts Target Price 143.8 29.2
ValueRay Target Price 111.8 0.44